Strengthening Salk’s faculty in the fields of cancer, Alzheimer’s, epigenetics, and AI
Every medical advance begins with a question no one has yet answered. This spring, the Salk Institute welcomed several new faculty members and recognized a key promotion, and each scientist brings a distinct set of questions that will deepen Salk’s foundational research in cancer, Alzheimer’s disease, epigenetics, and artificial intelligence. Thales “PapaG” Papagiannakopoulos, PhD, will join Salk as a professor in September 2026, coming from the NYU Grossman School of Medicine. His central question: How do tumors adapt when threatened? In addition to multiplying, cancer cells shift how they use energy, reshape the immune environment around them, and even communicate with the nervous system in ways that drive symptoms like fatigue and weight loss. In two recent studies published in Nature, PapaG’s team showed that disrupting specific proteins reduced lung and pancreatic cancer in laboratory experiments, pointing toward promising new therapeutic strategies. At Salk, PapaG will add momentum to the Institute’s National Cancer Institute-Designated Cancer Center and forge new collaborations across the Institute’s cancer, metabolism, immunology, andneuroscience programs. Ian Guldner, PhD, will join Salk as an assistant professor later in 2026, with his recruitment made possible by a gift from the Ray and Dagmar Dolby Family Fund. His question has…
